Torrent Pharma Gets Warning Letter From Usfda For Gujarat Facility

Torrent Pharma Gets Warning Letter From Usfda For Gujarat Facility

By, Admin 12 October 2019

Drug Firm Torrent Pharmaceuticals On Wednesday Said It Has Received A Warning Letter From The Us Health Regulator For Its Indrad Facility In Gujarat. This Action By The United States Food And Drug Administration (Usfda) Follows Earlier Intimation Received From The Regulator In August 2019, Wherein The Agency Had Classified Its Inspection As "Official Action Indicated" (Oai), Torrent Pharma Said In A Regulatory Filing.The Company Does Not Believe That The Warning Letter Will Have An Impact Of Disruption Of Supplies Or The Existing Revenues From Operations Of This Facility, It Added."We Will Be Engaging With The Agency And Are Fully Committed In Resolving This Issue At The Earliest," Torrent Pharma Said.The Company Is Also Committed In Maintaining The Highest Standards Of Compliances And Quality Manufacturing Across All Its Facilities, It Added.The Company, However, Did Not Share Any Details About The Concerns Raised By The Us Regulator In Its Warning Letter. Shares Of Torrent Pharmaceuticals Ltd Closed At Rs 1,666.15 Per Scrip On Bse, Up 3.26 Per Cent From The Previous Close.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!